Remarkably, both elevated TMAO plasma levels and the activation of Toll-like receptor (TLR) signaling by MAMPs were shown to accelerate atherogenesis in the apolipoprotein E (Apoe)-deficient mice, which are currently used as an animal model of atherosclerosis (17, 18). The gene discussed is APOE; the disease is atherosclerosis.